Drugmakers Mallinckrodt, Endo to Merge, Plan NYSE Listing
KEY TAKEAWAYS Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York Stock Exchange, the two drugmakers said Thursday.The new firm will have a pro forma enterprise value of $6.
Mallinckrodt and Endo plan merger as they look to recover from opioid litigation
The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in 2025 and at least $150 million of annual operating synergies by year three.
Drugmakers Mallinckrodt and Endo Are in Talks to Merge
Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people with knowledge of the matter said.
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger
Mallinckrodt and Endo, drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced plans Thursday to join forces in a deal valued at $6.7 billion. Mallinckrodt Chief Executive Siggi Olafsson said the companies' operations and products complement each other.
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm
Drugmaker Mallinckrodt struck a deal to buy Endo in an effort to build a diversified pharmaceuticals company with a hefty U.S. footprint.
Mallinckrodt Pharma, Endo Reach Deal for $6.7 Billion Merger
Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.
Mallinckrodt, Endo Enter $6.7 Billion Merger Deal as Drug Makers Plan New US Listing
Mallinckrodt and Endo are set to merge in a cash-and-stock deal valued at $6.7 billion, with the drug makers set to list shares of the new firm on the New York Stock Exchange. Shareholders in Endo, which makes sterile injectables and generic pharmaceuticals,
Veren, Whitecap Resources to merge in all-stock deal valued at ~$15B
Veren and Whitecap Resources announce a merger agreement in an all-share transaction valued at ~$15B including debt.
Kalaris and AlloVir Announce Stockholder Approval of Merger
The closing of the merger is expected to occur as soon as practicable, subject to the satisfaction or waiver of the remaining customary closing conditions. Following the closing of the merger, the ...
Spirit Airlines formally exits Chapter 11 bankruptcy with less debt, new stock
Spirit Airlines has officially exited Chapter 11 bankruptcy proceedings after shedding a large chunk of debt and receiving a ...
Whitecap-Veren Merger: Over 9% Dividend Yield And Still Growing With 2030 Projection
The C$15 billion Whitecap-Veren merger creates the 7th-largest Canadian oil & gas producer. Read why SPGYF and VRN stocks are ...
Stocktwits on MSN4d
Veren, Whitecap Resources To Merge In $10.4B All-Stock Transaction: Retail Optimism Climbs
Canadian oil companies Veren Inc. (VRN) and Whitecap Resources Inc. have agreed to merge in an all-stock transaction valued ...
M&A News: Paramount (NASDAQ:PARA) Merger May Go Back to Bid
That merger that entertainment giant Paramount (PARA) hoped would hit this summer may end up being off altogether. That visit ...
1 Stock Warren Buffett Could Target Next With Berkshire's $334 Billion Cash Pile
Despite his reputation as a long-term investor, Buffett has engaged in merger arbitrages for more than 30 years, including ...
Honda Stock Gains as Merger With Nissan Called Off
Honda's U.S.-listed shares are rising in premarket trading after the Japanese automaker and ailing domestic rival Nissan said they have called off merger plans announced in December.
Mallinckrodt and Endo to combine in stock and cash transaction
Specialty pharmaceutical companies Endo, Inc. (OTC:ENDPQ) and Mallinckrodt (OTC:MNKTQ) announced Thursday plans to combine in a stock and cash transaction worth $6.7B, creating a public firm listed on ...